Isabel Blancas (I Blancas)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Metastatic Breast Cancer

Estrogen Receptor

Cross Sectional

Top Venues

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Future oncology (London, England)

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Isabel Blancas, Marina Linares-Rodríguez, Celia Martín-Bravo, Celia Gómez-Peña, Fernando Rodríguez-Serrano
HER2/neu 655 polymorphism, trastuzumab-induced cardiotoxicity, and survival in HER2-positive breast cancer patients. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Isabel Blancas, Jessica Grosjean, Rebecca Pedersini, Carlotta Buzzoni, Ghassan Sleilaty, Alberto Molero, Antonella Tamma, Nadia Chouaki, Manuel Atienza, Anna Emde, Sara Siddi, Rodrigo Sanchez Bayona, Lucia Del Mastro, Walid Fakhouri
Abemaciclib for treating patients with HR+/HER2- metastatic breast cancer: a real-world study in France, Italy and Spain. Future oncology (London, England) (2024)
José Angel García-Saenz, Isabel Blancas, Isabel Echavarría, Carmen Hinojo, Mireia Margeli, Fernando Moreno Antón, Sonia Pernas, Teresa Ramon Y Cajal, Nuria Ribelles, Meritxell Bellet
SEOM-GEICAM-SOLTI clinical guidelines in advanced breast cancer (2022). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
José Angel García-Saenz, Isabel Blancas, Isabel Echavarría, Carmen Hinojo, Mireia Margeli, Fernando Moreno Antón, Sonia Pernas, Teresa Ramon Y Cajal, Nuria Ribelles, Meritxell Bellet
Correction to: SEOM-GEICAM-SOLTI clinical guidelines in advanced breast cancer (2022). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Isabel Blancas, C Olier, V Conde, J L Bayo, C Herrero, I Zarcos-Pedrinaci, F Carabantes, J M Baena-Cañada, J Cruz, M Ruiz-Borrego
Real-world data of fulvestrant as first-line treatment of postmenopausal women with estrogen receptor-positive metastatic breast cancer. Scientific reports 11 (1) (2021)